Ulrike Hövelmann

1.2k total citations
28 papers, 920 citations indexed

About

Ulrike Hövelmann is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ulrike Hövelmann has authored 28 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Surgery and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ulrike Hövelmann's work include Diabetes Management and Research (25 papers), Diabetes Treatment and Management (22 papers) and Pancreatic function and diabetes (14 papers). Ulrike Hövelmann is often cited by papers focused on Diabetes Management and Research (25 papers), Diabetes Treatment and Management (22 papers) and Pancreatic function and diabetes (14 papers). Ulrike Hövelmann collaborates with scholars based in Germany, Denmark and United States. Ulrike Hövelmann's co-authors include Tim Heise, Hanne Haahr, Leszek Nosek, Susanne Gammelgaard Bøttcher, Lutz Heinemann, Lise Brøndsted, Charlotte L. Adrian, Laurence Hirsch, Eric Zijlstra and Annelie Fischer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Diabetes.

In The Last Decade

Ulrike Hövelmann

27 papers receiving 882 citations

Peers

Countries citing papers authored by Ulrike Hövelmann

Since Specialization

Citations

This map shows the geographic impact of Ulrike Hövelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Hövelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Hövelmann more than expected).

Fields of papers citing papers by Ulrike Hövelmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Hövelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Hövelmann. The network helps show where Ulrike Hövelmann may publish in the future.

Co-authorship network of co-authors of Ulrike Hövelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Hövelmann. A scholar is included among the top collaborators of Ulrike Hövelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Hövelmann. Ulrike Hövelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetic and Pharmacodynamic Characteristics of Insulin Icodec After Subcutaneous Administration in the Thigh, Abdomen or Upper Arm in Individuals with Type 2 Diabetes Mellitus 2023 ·Clinical Drug Investigation ·Leona Plum‐Mörschel, (unknown), (unknown), Ulrike Hövelmann, (unknown), Niels Rode Kristensen, (unknown), Hanne Haahr	21
2	Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes 2023 ·Diabetes Obesity and Metabolism ·Simon Heller, Tadej Battelino, Timothy S. Bailey, Thomas R. Pieber, Ulrike Hövelmann, Leona Plum‐Mörschel, Anita E. Melgaard, Ronnie Aronson, Linda A. DiMeglio, Thue Johansen, Thomas Danne	1
3	Molecular and Biological Properties of Insulin Icodec, a New Insulin Analog Designed to Give a Long Half-Life Suitable for Once-Weekly Dosing 2022 ·Diabetologie und Stoffwechsel ·Ulrike Hövelmann, Erica Nishimura, Thomas Kjeldsen, František Hubálek, Tine Glendorf, Carsten E. Stidsen, (unknown), Thomas Åskov Pedersen, Anne Lützen, Lone Pridal, Peter Madsen	0
4	A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage 2022 ·SHILAP Revista de lepidopterología ·(unknown), Eugenia Migliavacca, Daniela Lamers, (unknown), John Corthésy, Gerard Vinyes-Parès, Nabil Bosco, Leonidas G. Karagounis, Ulrike Hövelmann, Tim Heise, Maximilian von Eynatten, Philipp Gut	12
5	Dasiglucagon—A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia: Results of Phase 3 Randomized Double-Blind Clinical Trial 2021 ·Diabetes Care ·Thomas R. Pieber, Ronnie Aronson, Ulrike Hövelmann, (unknown), Leona Plum‐Mörschel, Kim Knudsen, (unknown), Ramin Tehranchi	35
6	Pharmacokinetic and pharmacodynamic bioequivalence of biosimilar MYL‐1601D with US and European insulin aspart in healthy volunteers: A randomized, double‐blind, crossover, euglycaemic glucose clamp study 2021 ·Diabetes Obesity and Metabolism ·Ulrike Hövelmann, (unknown), (unknown), Mark Liu, (unknown), (unknown), Nilanjan Sengupta, (unknown), (unknown), Abhijit Barve	9
7	Pharmacokinetics and Glucodynamics of Ultra Rapid Lispro (URLi) versus Humalog® (Lispro) in Younger Adults and Elderly Patients with Type 1 Diabetes Mellitus: A Randomised Controlled Trial 2020 ·Clinical Pharmacokinetics ·Helle Linnebjerg, Qianyi Zhang, Elizabeth LaBell, Mary Anne Dellva, David E. Coutant, Ulrike Hövelmann, Leona Plum‐Mörschel, (unknown), Jennifer Leohr	45
8	Glucagon Administration by Nasal and Intramuscular Routes in Adults With Type 1 Diabetes During Insulin-Induced Hypoglycaemia: A Randomised, Open-Label, Crossover Study 2020 ·Diabetes Therapy ·Jeffrey G. Suico, Ulrike Hövelmann, Shuyu Zhang, Tong Shen, Brandon K. Bergman, Jennifer L. Sherr, Eric Zijlstra, Brian M. Frier, Leona Plum‐Mörschel	19
9	237-OR: Insulin Icodec: An Insulin Analog Suited for Once-Weekly Dosing in Type 2 Diabetes 2020 ·Diabetes ·Ulrike Hövelmann, Lise Brøndsted, Niels Rode Kristensen, Rasmus Ribel‐Madsen, J. Hans DeVries, Tim Heise, Hanne Haahr	34
10	Nasal Glucagon: Potentially Viable Alternative to Treat Insulin-Induced Hypoglycemia in Adults with Type 1 Diabetes 2018 ·Canadian Journal of Diabetes ·Jeffrey G. Suico, Ulrike Hövelmann, Shuyu Zhang, Tong Shen, Brandon K. Bergman, Jennifer L. Sherr, Eric Zijlstra, Brian M. Frier, Leona Plum‐Mörschel	1
11	Ultra-rapid Lispro (URLi) Shows Faster Absorption of Insulin Lispro vs. Humalog® during Insulin Pump (CSII) Use in Patients with T1D 2018 ·Diabetes ·Christof Kazda, Jennifer Leohr, Rong Liu, Thomas A. Hardy, Shobha Reddy, (unknown), (unknown), Ulrike Hövelmann, Christoph Kapitza	6
12	Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions 2017 ·Clinical Drug Investigation ·Ulrike Hövelmann, Tim Heise, Leszek Nosek, (unknown), Karen Thomsen, Hanne Haahr	25
13	A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus 2016 ·Drugs & Aging ·Tim Heise, Ulrike Hövelmann, Eric Zijlstra, Kirstine L. Stender-Petersen, Jacob Jacobsen, Hanne Haahr	31
14	Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus 2016 ·Clinical Pharmacokinetics ·Tim Heise, Kirstine L. Stender-Petersen, Ulrike Hövelmann, Jacob Jacobsen, Leszek Nosek, Eric Zijlstra, Hanne Haahr	51
15	Faster‐acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart 2015 ·Diabetes Obesity and Metabolism ·Tim Heise, Ulrike Hövelmann, Lise Brøndsted, Charlotte L. Adrian, Leszek Nosek, Hanne Haahr	114
16	Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine 2015 ·Expert Opinion on Drug Metabolism & Toxicology ·Tim Heise, Ulrike Hövelmann, Leszek Nosek, (unknown), Susanne Gammelgaard Bøttcher, Hanne Haahr	109
17	Insulin degludec has a two-fold longer half-life and a more consistent pharmacokinetic profile compared with insulin glargine 2012 ·Tim Heise, Ulrike Hövelmann, Leszek Nosek, Susanne Gammelgaard Bøttcher, Charlotte Granhall, Hanne Haahr	39
18	Microneedle-Based Intradermal Versus Subcutaneous Administration of Regular Human Insulin or Insulin Lispro: Pharmacokinetics and Postprandial Glycemic Excursions in Patients with Type 1 Diabetes 2011 ·Diabetes Technology & Therapeutics ·Ronald J. Pettis, Laurence Hirsch, Christoph Kapitza, Leszek Nosek, Ulrike Hövelmann, (unknown), Diane Sutter, Noel G. Harvey, Lutz Heinemann	55
19	Insulin Glulisine Has a Faster Onset of Action Compared with Insulin Aspart in Healthy Volunteers 2010 ·Experimental and Clinical Endocrinology & Diabetes ·Sabine Arnolds, Klaus Rave, Ulrike Hövelmann, Annelie Fischer, (unknown), Tim Heise	34
20	Continuous Glucose Monitoring during Exercise in Patients with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion 2010 ·Journal of Diabetes Science and Technology ·Christoph Kapitza, Ulrike Hövelmann, Leszek Nosek, (unknown), Matthias Essenpreis, Lutz Heinemann	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact